Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy

Fig. 2

Timeline for study. Daily DRS measurements were taken after tumor volumes reached 75 mm3 up until endpoint analysis (Day 3 or 12). Therapy injections were given on days 0 to 10. 5-FU treated mice were given daily injections while the other treatment groups (saline and isotype controls and anti-CCL2) were given injections every other day. The combination group followed the treatment schedule of the anti-CCL2 and 5-FU groups. Figure was created with BioRender.com

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us